Navigation Links
CMV Vaccine Prototype Successfully Tested in Guinea Pigs

her Communication Disorders. Every year, 0.5 to 2.5 percent of babies born in the United States are infected with CMV. The virus is transmitted to the fetus through the mother’s placenta.

Dr. Schleiss said that 10 percent to 15 percent of babies with congenital CMV have a long-term disability such as mental retardation, cerebral palsy, and hearing loss. The infection could potentially cause other developmental disabilities such as autism or attention deficit disorder. The virus can also damage the placenta, leading to pregnancy loss.

CMV is present in bodily secretions and is spread through close personal contact, such as kissing or sharing eating utensils. For example, an infant in daycare could give the virus to her pregnant mother by kissing her on the lips, said Dr. Schleiss. The virus can enter through mucosal surfaces such as the mouth or breaks in the skin. It can also be transmitted through nasal secretions, blood transfusions, and sexual contact. Most adults will become infected with CMV at some point during their lives. Dr. Schleiss added that pregnant women may not even know they have the infection.

CMV Vaccine Prototype

The experimental vaccine differs from traditional vaccines, which are made from a whole killed virus. Called a vector vaccine, the experimental vaccine uses an altered virus to deliver one gene from the viral DNA to the animal’s cells. The cells then begin manufacturing the viral protein. Cells of the guinea pigs’ immune system detect the viral protein and launch an attack against it. In so doing, they learn to recognize CMV. The gene used in the experimental guinea pig CMV vaccine—UL83, also called pp65—contains the information needed to make a protein involved in the infection process. The virus used to make the vector vaccine (Venezuelan Equine Encephalitis Virus) was altered by removing 40 percent of the virus’ genes, to prevent it from reproducing and infecting new hosts.

Th
'"/>




Page: 1 2 3

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
... to determine and help patients to have a recurren...chemotherapy drugs docetaxel (Taxotere) and vinore...es.// It was previously reported by the Finnish r...fusions of trastuzumab (Herceptin) were less likel...
...nfocomm, which helped SARS affected South-East Asi...thermal scanners are now under the process of desi...is of the bird flu and isolate people affected by ...sion from the central and state government by send...
... delivery even if not needed they should be asked ...ugh the experts at Royal College of Midwives (RCM)...g number of women asking for the injection. About ...idural, which costs about ?500 in a private matern...
...in its sordid journey. Tracing its beginnings, res... involvement in the development of cancer. // It w...may hold clues for lasting remedy of the diseased ...th every tumor, there are abnormal stem cells that...
Other Medicine News:Health News:Trails to detect effective breast cancer drugs that reduces recurrences 2
(Date:10/8/2008)...l program to evaluate TAXUS(R) Element(TM) Platinu... NATICK, Mass., Oct. 8 /- B...nnounced that it has completed enrollment in,the P...hird-generation,TAXUS(R) Element(TM) paclitaxel-el... has enrolled nearly 1,500 patients at 100 U.S. an...
(Date:10/8/2008)...ory study shows clinical improvement in patients w...-- Current treatment options have limited benefit...nd incurable blood vessel disease, -- Imatinib ... certain cancers, known to inhibit protein as...re potential of imatinib mesylate in PAH in 2...
(Date:10/7/2008)... the efficacy of new device for detecting polyps t...onoscopy, ORLANDO, Fla., Oct. 7 /- A...Scientific Meeting in Orlando (ACG 2008), renowned...esults from a,multi-institutional clinical study t...roscope(R), a new device that is designed to impro...
(Date:10/7/2008)...Oct. 7 / Burcon NutraScienc... Puratein(R) and,Supertein(TM) canola protein isol...heir intended use in a variety of food and beverag...ed GRAS through an,independent evaluation by a pan...ty, toxicology, nutritional sciences, food allergi...
Breaking Medicine Technology:Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Burcon announces GRAS status for Puratein(R) & Supertein(TM) 2Burcon announces GRAS status for Puratein(R) & Supertein(TM) 3New Book Looks at Clinical Research from the Patients Point of View 8546 1New Book Looks at Clinical Research from the Patients Point of View 8546 2New Book Looks at Clinical Research from the Patients Point of View 8546 3Top U S Cloning Companies Announce New System to Track Cloned Livestock 2303 1Top U S Cloning Companies Announce New System to Track Cloned Livestock 2303 2Statement of International Dairy Foods Association President and CEO Connie Tipton 2300 1Statement of International Dairy Foods Association President and CEO Connie Tipton 2300 2Possible New Way to Detect Monitor Liver Disease Without Painful Liver Biopsy 2297 1Possible New Way to Detect Monitor Liver Disease Without Painful Liver Biopsy 2297 2
...ws Promise As an Adjuvant for Vaccines,against Avi...7, 2007 /PRNewswire-FirstCall/ -- IR,BioSciences H...a,from its influenza vaccine adjuvant study being ...es Homspera elevates host,immune responsiveness ab...sults are from an ongoing study, and are a strong,...
...7, 2007 /PRNewswire-FirstCall/ --,Citing issues re...g,of paclitaxel, Conor Medsystems, LLC has conclud...Antiproliferative for Restenosis),trial, the pivot...-eluting coronary stent, failed to meet its primar...es, and the overall,rates of death, myocardial inf...
Other Medicine Technology:IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 2IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 3IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 4Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent,Trial Conclusions 2Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent,Trial Conclusions 3Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent,Trial Conclusions 4
...th EnCap technology is used for cardiac and great ...losure. It is glutaraldehyde-treated bovine perica...ty, plus improved suturability and handling over s...tch product is the ability to prevent calcificatio...
Unique triaxial catheter design and ergonomic handle for easy and accurate deployment. Six proprietary radiopaque Nitinol markers on the proximal and distal ends of the stent enhance visibility. Corr
Supreme and Response catheters comprise the world's broadest line of fixed-curve catheters available for electrophysiology procedures. Their advanced catheter design and materials technology provide
Coaxial Multicolor LIO Worlds first coaxial multicolor LIO provides precise laser delivery with repeatable outcomes, as well as maximum treatment options and physician safety.
Medicine Products: